Hint mode is switched on Switch off
For swift navigation between sections

Ascentage Pharma Group International
LEI 300300WBVGZIXEF27W64

Organization name
Ascentage Pharma Group International
Country name
China
Country of registration
Cayman Islands
Industry
Miscellaneous Healthcare: Products and Services
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Quotes

Request sent
Access denied
Quotes provided by information providers are indicative in nature

Profile

Ascentage Pharma Group International operates as a clinical-stage biotechnology company. The Company develops novel therapies for cancers, hepatitis B virus, age-related diseases, and more. Ascentage Pharma Group International conducts businesses in China, the United States, and other countries.

Awards

Documentation

IFRS/US GAAP reports

2025
2024
Show all Hide
Authorization required
You need to request access

Stocks

Public debt by currencies

Codes

  • LEI
    300300WBVGZIXEF27W64
  • SIC
    2834 PHARMACEUTICAL PREPARATIONS
  • NACE
    *** ***
  • NAICS
    *** ***
  • CIK
    0002023311
Registration is required to get access.